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Abstract
Chaperone synthesis in response to proteotoxic stress is dependent on a family of transcription factors named heat shock
factors (HSFs). The two main factors in this family, HSF1 and HSF2, are co-expressed in numerous tissues where they can
interact and form heterotrimers in response to proteasome inhibition. HSF1 and HSF2 exhibit two alternative splicing
isoforms, called a and b, which contribute to additional complexity in HSF transcriptional regulation, but remain poorly
examined in the literature. In this work, we studied the transcriptional activity of HSF1 and HSF2 splicing isoforms
transfected into immortalized Mouse Embryonic Fibroblasts (iMEFs) deleted for both Hsf1 and Hsf2, under normal conditions
and after proteasome inhibition. We found that HSF1a is significantly more active than the b isoform after exposure to the
proteasome inhibitor MG132. Furthermore, we clearly established that, while HSF2 had no transcriptional activity by itself,
short b isoform of HSF2 exerts a negative role on HSF1b-dependent transactivation. To further assess the impact of HSF2b
inhibition on HSF1 activity, we developed a mathematical modelling approach which revealed that the balance between
each HSF isoform in the cell regulated the strength of the transcriptional response. Moreover, we found that cellular stress
such as proteasome inhibition could regulate the splicing of Hsf2 mRNA. All together, our results suggest that relative
amounts of each HSF1 and HSF2 isoforms quantitatively determine the cellular level of the proteotoxic stress response.
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Introduction
Proteasome is a major protein complex responsible for regulated
degradation of intracellular proteins, and its activity is modified in
many disorders. For example, a decrease in proteasome activity is
associated with neurodegenerative diseases, whereas an increase
catalytic activity is associated with cancers [1]. Thus, proteasome
is a prime target in cancer therapy and bortezomib was the first
proteasome inhibitor authorized as anti-tumor agent in humans.
In a previous work, we have shown that proteasome subunit
expression was regulated by heat shock factors [2]. Heat shock
factor 1 (HSF1) and heat shock factor 2 (HSF2) belong to the
family of transcription factors, which are essential for the
expression of heat shock proteins (Hsps) in response to protein
insults. HSF1 is the main factor responsible for Hsp induction,
which is abolished in HSF1 deficient cells or organism, and cannot
be rescued by HSF2 alone [3]. Among proteotoxic stress,
proteasome inhibition, but not heat shock, activates HSF2 [4].
Interestingly, it was shown that after treatment with MG132, a
classical proteasome inhibitor, HSF1 and HSF2 can form
heterotrimers and bind to DNA [5]. The exact role of such
heterotrimers is not yet fully understood, but it was proposed that
HSF2 could act as a modulator of HSF1 activity [6–7].
Moreover, both HSF1 and HSF2 exist under two different
isoforms produced by alternative splicing. This increases the
diversity of potential HSF homo and heterotrimers and adds more
complexity to HSF regulation. Regarding HSF1, only two
publications refer to the existence of two splicing isoforms (Hsf1a
and Hsf1b) in mice [8–9]. Hsf1a results from a splicing process
maintaining the insertion of the exon 11 (66 bp), and thus
producing a longer protein in comparison to the b isoform. This
exon is flanked by two introns presenting a consensus-splicing site.
The 22 amino acids encoded by exon 11 are located in the C-
terminal domain, adjacent to the hydrophobic region C (HR-C)
that is important to maintain HSF1 under an inactive form in
absence of stress signal. This additional region could form a
leucine-zipper pattern possibly involved in the temperature
activation of HSF1a [9]. Furthermore, it was shown that the
relative quantity of both isoforms was regulated in a tissue specific
manner in mice, but surprisingly, their transcriptional activities
have never been studied so far. Like HSF1, the long and short
HSF2 isoforms are named HSF2a and HSF2b, respectively [10].
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HSF2a contains also an alternative exon 11, which is similarly
flanked by two introns containing consensus-splicing sites. Hsf2
exon 11 encodes an 18 amino acids region located after HR-C and
partially overlapping the activation domain called AD-1. The
relative quantity of HSF2 isoforms is tissue specific [8,10].
Activities of HSF2 isoforms have been better documented in
studies mainly conducted in K562 erythroleukemia cells, since
HSF2 activity is particularly efficient in these cells. Overexpression
of HSF2b resulted in a weaker Hsp70 induction compared to
HSF2a [11]. This confirmed previous work showing that HSF2a
is a more potent transcriptional activator than the HSF2b isoform
[10]. However, as K562 erythroleukemia cells contain a mixture
of both HSFs in their two existing isoforms, it is difficult to
distinguish the actual role of each isoform in the context of
heterotrimers.
Since the consequences of proteasome inhibition on HSF1 and
HSF2 isoform expression and activity have not yet been fully
characterized, we took advantage of existing cells which are
deficient for both HSF1 and HSF2. Using defined transfections,
we sought to determine the distinct role of each HSF1 and HSF2
isoforms independently of endogenous HSFs. Here, we show that
HSF1a and HSF1b exert different transcriptional activity and we
provide evidence for a specific repressor role of HSF2b. Finally,
our data and analyses establish that the relative quantity of each
HSF2 isoforms is regulated in a stress-dependent manner.
Materials and Methods
Animals, Embryos and Cell Culture
Mixed genetic background wild type, hsf12/2 and Hsf22/2
mice, previously provided by Dr IJ Benjamin (University of Utah,
Salt Lake City) and described elsewhere [12], were used in those
experiments. For embryos collection, females were superovulated
and mated with males of corresponding genotypes as described in
[13]. Plug was considered as day 0.5 after fertilization (0.5 days
post coitum (dpc)) and embryos were collected at the 2-cell stage
(1.5 dpc) to be cultured to the blastocyst stage as previously
described [13]. Blastocysts were obtained on 3–3.5 dpc and used
to perform real time RT-PCR.
Immortalized Mouse Embryonic Fibroblasts wild type (WT) or
deleted for both Hsf1 and Hsf2 (Hsf1.22/2) were obtained by
intercrossing single knockout mice [12,14]. The primary cells were
then immortalized using SV40 large T antigen by Dr Vale´rie
Mezger (UMR CNRS 7216, Paris, France). Cells were cultivated
as previously described [2].
Plasmid Constructs
pHSE2x-TATA-Firefly luciferase was obtained by cloning two
synthetic HSEs (59-GAAgcTTCtaGAAgcTTCtaGAAgcTTC-39)
followed by a TATA box into the pGL3 vector (Promega) at KpnI
and SacI sites. The plasmid pTK-Renilla luciferase (gift from Dr
Island, INSERM U991, Rennes, France) was used as control to
normalize transfection efficiency. All Hsf isoforms were cloned in
pCR3.1 expression vector (Invitrogen). For Hsf1a, the coding
sequence was amplified by RT-PCR from total RNA of iMEFs
WT, using primers flanking the open reading frame and providing
restriction site for EcoRI and NotI. Then, PCR fragment was
cloned to pCR3.1 and the cloned isoform was verified by
sequencing. The Hsf1b and Hsf2b cDNAs (in pGEM1-HSF1b
and pGEM-HSF2b vector, respectively) were a gift from Dr
Richard Morimoto (Northwerstern University, Evanston IL, USA)
and they were subcloned in pCR3.1 at EcoRI site. The pbactin-
HSF2a vector was a gift of Dr Kevin Sarge (University of
Kentucky, Lexington KY, USA) and the cDNA was also
subcloned in pCR3.1 at EcoRI and NotI sites.
Transfection and Luciferase Assay
All transfections were performed using JetPEI (Polyplus
Transfection) according to the manufacturer’s instructions. Cells
were harvested 24 h after transfection and 8 h of treatment with
MG132 at 2.5 mM, or with an equivalent volume of dimethyl
sulfoxide (DMSO) as control. For heat shock experiment, cells
were maintained at 45uC during 20 min and then transferred at
37uC during 6 h for recovery. Firefly luciferase and Renilla
luciferase activities were determined with Dual luciferase reporter
assay (Promega).
RT-PCR Analysis
One million of WT iMEFs were plated on a 10 cm dish and
treated with MG132 at 1 mM during 2 h, 4 h, 6 h, 8 h or 10 h.
After 10 h of MG132 treatment, cells were allowed to recover for
1 h, 6 h or 10 h, and then harvested. Total RNAs were extracted
with TRIzol reagent (Invitrogen) and 5 mg of RNAs were retro-
transcribed using M-MLV RT (Invitrogen). To discriminate
Hsf2a and Hsf2b, primers flanking alternative exon (forward:
CATGTCTAGTGCTGTCCAGC and reverse: 59-GAGCT-
CATCGACTTCTATGG-39) were used in RT-PCR experiment.
RT-PCR of the housekeeping gene Glyceraldehyde-3-phosphate
deshydrogenase (Gapdh) (forward: 59-TGAAGCAGGCATCT-
GAGGG-39 and reverse: 59-CGAAGGTGGAAGAGTGGGAG-
39) was used as control for the quality of extraction and retro-
transcription. Densitometric analysis was made with Quantity One
software (Bio-Rad).
RT-real time PCR experiments were performed on blastocysts
as described in [15]. Experiments to determine the relative
abundance of Hsf2 isoforms used primers to detect the total
population of Hsf2 transcripts (Hsf2 forward: 59-AGGGGAGTA-
Figure 1. Transcriptional activity of HSF1 and HSF2 isoforms. (A) Hsf1.22/2 iMEFs were co-transfected with increasing quantity of pCR3.1-
HSF1a (left), or pCR3.1-HSF1b (right), in addition to pHSEx2-TATA-Luc used as a reporter gene. DNA quantities were adjusted with empty pCR3.1.
Transfection efficiency was assessed using the pTK-Rluc reporter gene. Cells were treated with MG132 at 2.5 mM (white) or with DMSO (black) as
control, for 8 h. Results correspond to the ratio between firefly luciferase (FLucif) and renilla luciferase (RLucif) activities. The data are from a
representative experiment including three independent replicates (mean +/2 SD). (B) Representative Western-blot showing the expression of HSF1
isoforms after transfection. Hsf1.22/2 iMEFs were co-transfected with increasing quantity of pCR3.1-HSF1a (left) or pCR3.1-HSF1b (right) and pEGFP as
control for transfection efficiency. Cells were treated with MG132 at 2.5 mM and immunoblots for HSF1 and GFP were performed. (C) Hsf1.22/2 iMEFs
were co-transfected with 12.5 ng of pCR3.1-HSF1a (full line), or pCR3.1-HSF1b (dotted line), with two reporter genes described previously. Cells were
treated with MG132 at 2.5 mM or with DMSO, for 2 h, 4 h, 6 h or 8 h. Results correspond to the ratio between firefly luciferase (FLucif) and renilla
luciferase (RLucif) activities and are the mean of three independent experiments +/2 SD. (D) Hsf1.22/2 iMEFs were co-transfected with 12.5 ng of
pCR3.1-HSF2a, or pCR3.1-HSF2b, with the reporter genes as described in (A). Cells were treated with MG132 at 2.5 mM (black), or with DMSO (white),
for 8 h. Results are expressed in percentage of empty vector and represent the mean of three independent experiments +/2 SD (Student’s t test, ns:
no significant). (E) Representative Western-blot showing the expression of HSF2 isoforms after transfection. Hsf1.22/2 iMEFs were co-transfected with
increasing quantity of pCR3.1-HSF2a (high panel) or pCR3.1-HSF2b (low panel) and pEGFP as control for efficiency. Cells were treated with MG132 at
2.5 mM and immunoblots for HSF2 and GFP were performed.
doi:10.1371/journal.pone.0056085.g001
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CAACTGCATCG-39and reverse: 59- CAGGCGGACAAGCT-
TACTC-39) [16] and primers designed to amplify only Hsf2a
isoform (forward: 59-AGTTCTGTGCAGATGAATCCCACAG-
39 and reverse: 59-GCAGATGCAGAGTTCCCATCC-39). Exper-
iments performed to measure Hsp70.1 transcripts used the
following primers: Hsp70.1 forward: 59-TTGTCCATGT-
TAAGGTTTTGTGGTATA-39, Hsp70.1 reverse: 59-
GTTTTTTTCATTAGTTTGTAGTGATGCAA-39. The ex-
periments were performed at least in duplicate with one or two
independent groups of embryos included in each experiment
(n = 20 blastocysts). Results were normalized using 18S RNA
amplification.
Protein Extracts and Immunoblot Analysis
To evaluate protein expression after transfection, 200 000
Hsf1.22/2 iMEFs per well were seeded in a 6-well plate. Cells
were transfected as described above and were harvested after 24 h
of transient expression and 8 h of treatment with MG132 at
2.5 mM. To analyze the expression of endogenous HSF2, 1 million
of WT cells were plated in a 10 cm dish and were treated the next
day with MG132 at 1 mM, or with DMSO for 10 h. Whole cells
extracts were prepared with NP-40 lysis buffer (50 mM Tris-HCl
pH 8, 150 mM NaCl, 10 mM EDTA, 1% NP-40, 0.2% sarkosyl).
Proteins were separated on an 8.5% or a 12% polyacrylamide gel
to discriminate HSF2 isoforms and transferred to a nitrocellulose
membrane (Amersham Bioscience). Anti-HSF1 (4B4) antibody
(ab44819), anti-HSF2 (3E2) antibody (sc-13517) and Anti-GFP
antibody (a11122) were purchased from Abcam, Santa Cruz
Biotechnology and Molecular Probes, respectively.
Four hours of migration at 40 mA were necessary to separate
HSF2a and HSF2b. Ponceau staining was performed to assess
equal loading in place of classical actin control, which was
excluded from the gel during the long electrophoresis.
Co-immunoprecipitation
Hsf1.22/2 iMEFs were transfected with pHSF1b-EGFP and/or
with pCR3.1-HSF2a, or with pCR3.1-HSF2b. As control, cells
were co-transfected with pEGFP and pCR3.1-HSF2a, or pCR3.1-
HSF2b. Cells were treated with MG132 at 1 mM during 10 h.
Anti-GFP antibody (A11122, Molecular Probes) was used for
immunoprecipitation, carried out with Nuclear Complex Co-
immunoprecipitation kit (Active Motif), according to manufactur-
er’s instructions.
Results
Transcriptional Activities of HSF1 and HSF2 Splicing
Isoforms
To characterize the transactivation abilities of HSF1 isoforms,
we first co-transfected increasing doses of expression vector coding
either HSF1a or HSF1b, in Hsf1.22/2 iMEFs, with pHSE2x-
TATA-Firefly luciferase as a reporter gene. Then, cells were
treated with MG132 at 2.5 mM for 8 h. As presented in Figure 1A,
low quantities of HSF1a expression vector provided high level of
transactivation and HSF1a exhibited 1.4 times higher plateau
values than HSF1b. These data suggested that the a isoform was
more efficient than the b one to activate HSE-dependent
transcription under proteasome inhibition. Nevertheless, increas-
ing quantities of transfected HSF1a vector was accompanied by a
more pronounced basal activity (around 10 fold for 5 ng of
transfected vector/1000 cells), indicating that the a isoform
presents a weak stress-independent activity. To verify that the
difference observed in transactivation abilities was not due to a
defect in the level of expression of the transcription factors,
immunoblots were performed with extracts from Hsf1.22/2
iMEFs that had been co-transfected with an increased quantity
of pCR3.1-HSF1a or pCR3.1-HSF1b, in addition to pEGFP used
as a transfection efficiency control (Figure 1B). All cells were
treated with MG132 at 2.5 mM for 8 h. HSF1a protein (left panel)
became detectable when 3.125 ng of vector were transfected per
1000 cells, whereas HSF1b was detected after transfection of a
lower amount of vector (0.78 ng/1000 cells), suggesting that the b
isoform was more stable than the a isoform, but less effective from
a transcriptional point of view. Moreover, both HSF1 isoforms
required approximately 80 and 20 fold higher quantity of
transfected vector to be detected by immunoblot in comparison
to the amount needed to obtain a visible effect by luciferase assay.
These results suggest that a very low HSF1 intracellular
concentration is sufficient to activate transcription.
To study the kinetic of transactivation of each isoform, we co-
transfected 12.5 ng of expression vector in Hsf1.22/2 iMEFs.
Then, cells were treated with MG132 at 2.5 mM for 2 h, 4 h, 6 h
or 8 h. Stress-dependent induction of transcription was detectable
after 4 h of treatment (Figure 1C), showing that both isoforms
exhibited similar responses in terms of activation time course.
Finally, HSF2a or HSF2b expression vector were co-transfected
with pHSEx2-TATA-Firefly luciferase in Hsf1.2
2/2 iMEFs.
Neither HSF2a nor HSF2b induced the transcription of the
HSE reporter gene after treatment with MG132 at 2.5 mM
(Figure 1D). Two other reporter genes, containing either HSP70
or p35 gene promoters, were used in similar experiments and gave
comparable results since both HSF2 isoforms were unable to
significantly trigger Hsp70 or p35 transactivation (data not shown).
These data suggest that by itself, HSF2 is a very poor transcription
factor, whatever the splicing isoform considered. As previously
tested for HSF1, Hsf1.22/2 iMEFs were co-transfected with
increasing quantity of pCR3.1-HSF2a or pCR3.1-HSF2b, in
addition to pEGFP used as a transfection efficiency control, to
assess the level of expression of the different vectors (Figure 1E).
Like for HSF1 isoforms, a minimum of 3.125 ng transfected vector
Figure 2. HSF2b interacts with HSF1b and inhibits its transcriptional activity. (A) Hsf1.22/2 iMEFs were co-transfected with 12.5 ng of
pCR3.1-HSF1a or pCR3.1-HSF1b in combination with 12.5 ng of pCR3.1-HSF2a, or pCR3.1-HSF2b. Transcriptional activity was followed with pHSEx2-
TATA-Luc, and pTK-Rluc was used as control for transfection efficiency. Cells were treated with MG132 at 2.5 mM (white), or with DMSO as control
(black). Results correspond to the ratio between firefly luciferase (FLucif) and renilla luciferase (RLucif) activities and are a representative experiment
made with three independent replicates (Student’s t test: HSF1a or b alone compared to others conditions. **p,0.01, ns: no significant). (B) Cells
were transfected with the indicated expression vectors and the reporter genes, as described in (A). Cells were submitted to heat shock at 45uC for
20 min and put to recovery at 37uC for 6 h (grey). Untreated cells served as control (black). Results are the mean +/2 SD of 9 to 12 independent
transfections. (C) Hsf1.22/2 iMEFs were co-transfected with pCR3.1-HSF1b (gray) and with an increase quantity of pCR3.1-HSF2a (white), or pCR3.1-
HSF2b (black). Then, cells were treated with MG132 at 2.5 mM for 8 h. Results are expressed in percentage of HSF1b activity and are the mean of three
independent experiments +/2 SD (Student’s t test: HSF1b alone compare to others conditions. *p,0.05, **p,0.01, ns: no significant). (D)
Representative co-immunoprecipitation experiments. Hsf1.22/2 iMEFs were co-transfected with pEGFP or pHSF1b-EGFP, in combination with pCR3.1-
HSF2a or pCR3.1-HSF2b. Cells were treated with MG132 at 1 mM for 8 h and nuclear protein extracts were submitted to EGFP immunoprecipitation,
followed by immunoblotting for HSF2. The value of the IP/Input ratio is indicated below the panel.
doi:10.1371/journal.pone.0056085.g002
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per 1000 cells was necessary to detect HSF2a whereas only
0.78 ng per 1000 cells was required for HSF2b, suggesting that
this latter isoform is more stable than HSF2a.
HSF2b Forms Heterotrimers with HSF1b and Inhibits its
Transcriptional Activity
Previous work from our team had shown that proteasome
inhibition was associated with the formation of HSF1/HSF2
heterotrimers [5]. To determine how the different splicing
isoforms could impact heterotrimer activity, we co-transfected
different combinations of expression vectors with reporter genes in
Hsf1.22/2 iMEFs (Figure 2A). HSF1a transcriptional activity was
not statistically different in absence or presence of HSF2 isoforms.
Likewise, HSF1b transcriptional activity was not altered when co-
transfected with HSF2a. However, it was strongly and significantly
decreased (3 fold) after co-transfection with HSF2b. The activity of
Figure 3. Ratio between HSF2a and HSF2b controls HSF1b transcriptional activity. (A) Representative Western-blot showing the expression
of HSF2 isoforms after transfection. Hsf1.22/2 iMEFs were co-transfected with pCR3.1-HSF1b and pCR3.1-HSF2a/b to obtain the expression of
equivalent amounts of HSF1 and HSF2, and increasing concentration of HSF2b relatively to HSF2a. Cells were treated with 2.5 mM MG132 for 8 h.
Protein extracts were loaded on 12% polyacrylamide gel and submitted to a long migration to separate efficiently HSF2 isoforms. HSF2 was revealed
by immunobloting. (B) Transcriptional activity induced, with fixed concentrations of HSF1 and total HSF2, but varying combinations of HSF2b/HSF2a.
Hsf1.22/2 iMEFs were co-transfected with 12.5 ng of pCR3.1-HSF1b and with the same quantity of pCR3.1-HSF2a/b, as previously described.
Diamonds correspond to the experimental data obtained in independent triplicates, and expressed as percentage of maximal activity. Solid line
drawn to equation 2 with random multimerization and considering that HSF1 is active only in absence of HSF2b in the trimer. (C) HSE-driven
transcriptional activities expected from Eq. 2, with a constant and identical amounts of HSF1 and total HSF2, and when increasing the ratio HSF2b/
HSF2a. The transcriptional strength of a trimer is assumed to be proportional to the number of HSF1 monomers present, and the unit of
transcriptional strength (k= 1) corresponds to that of an HSF1 monomer. The strength of trimerization is considered as either (i) identical between
hetero- and homodimers (plain line), (ii) 10 fold higher for homodimers (dashed line), or (iii) 10 fold higher for heterodimers (dotted line). (D) HSE-
driven transcriptional activities drawn to Eq. 2, with constant and equivalent amounts of HSF1 and HSF2, capable to either randomly homo- or
heterotrimerize. Plain line: as for panel C, the transcriptional strength of a trimer is proportional to the number of HSF1 monomers included in the
trimer and the strength of a HSF1 monomer is set to 1 (k3 = 3 k1 and k2 = 2 k1 and k1 = 1). Dashed line: Transcriptional strength independent on
whether the trimer contains 1, 2 or 3 HSF1 monomers (k1 = k2 = k3 = 1). Dotted line: same rule with k1 = k2 = k3 = 3.
doi:10.1371/journal.pone.0056085.g003
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the heterotrimer was also assessed after heat shock (Figure 2B).
When HSF1 isoforms were transfected alone, the same transacti-
vation level was observed whatever the isoform used. As observed
after MG132 treatment, HSF2a and HSF2b did not show any
significant transcriptional activity under thermal stress. Co-
transfection of HSF2 with HSF1 did not affect HSF1 activity.
Especially, the combination of HSF1b with HSF2b did not
decrease the trimer activity after heat shock, in contrast to MG132
treatment.
To verify that the inhibition observed in MG132 experiment
was due to HSF2b itself and not to a side effect related to
difference in transfection efficiency, we performed a dose effect
experiment (Figure 2C). Hsf1.22/2 iMEFs were co-transfected
with a constant quantity of pCR3.1-HSF1b and increasing doses
of pCR3.1-HSF2a or pCR3.1-HSF2b. HSF1b transactivation
remained similar whatever the amount of co-transfected HSF2a.
On the contrary, HSF2b transfection provoked a sharp decrease of
transactivation with low dose (5 ng/1000 cells), confirming the
inhibitory role of HSF2b.
The ability of each HSF2 isoform to associate with HSF1b in
response to MG132 treatment was determined by co-immuno-
precipitation experiment (Figure 2D). Hsf1.22/2 iMEFs were co-
transfected with expression vector coding either HSF1b-EGFP or
only EGFP, in association with HSF2 isoforms. Immunoprecip-
itation was performed with antibodies against EGFP and blots
were probed with HSF2 antibodies. Cells transfected with HSF1b-
EGFP, but not HSF2, were used as control and showed no signal
after immunoprecipitation, demonstrating that the HSF2 anti-
bodies do not cross-react with HSF1b (lane 3). Interestingly, we
found that both HSF2a and b isoforms interact with HSF1b (lane
4 and 5) indicating the formation of heterotrimers. Moreover,
HSF2 co-immunoprecipitation required the presence of HSF1, as
demonstrated by its absence in the EGFP control (lane 1 and 2).
Influence of the HSF2b/HSF2a Ratio on HSF1
Transcriptional Activity
To determine how the HSF2b/HSF2a ratio impacts the
transcriptional activity of HSF1b, Hsf1.22/2 iMEFs were trans-
fected with HSF1b and the same amount of total HSF2, including
variable HSF2b/HSF2a ratios (Figure 3). HSF2 proteins were first
quantified by immunoblotting (Figure 3A) and densitometric
analyses. Due to the differences in protein stability of HSF2
isoforms, we calculated from three densitometric analyses a
corrective coefficient, linking transfected vector ratio and protein
expression. Then, the same transfection conditions were used to
measure the transcriptional activity with a luciferase reporter
vector (Figure 3B). HSE-driven transcriptional activity diminished
when increasing the HSF2b/HSF2a protein ratio. The capacity of
HSF2 and HSF1 to heterotrimerize has been evidenced [5,17] but
the stoichiometry of the different HSFs in the trimers remains
unknown. Moreover, the kinetic and thermodynamic parameters
of HSF trimerization, as well as the precise mode of stepwise HSF
assembly, ordered or random, have to be characterized. Hence, in
absence of defined data, minimal rules were selected, as listed
below. It is considered that HSF2a has no influence on the
transcriptional activity of the HSF1 protomers included in a
Figure 4. Proteasome inhibition modifies the relative quantity of Hsf2a and Hsf2b at the mRNA level. (A) WT iMEFs were treated with
MG132 at 1 mM or with DMSO for 10 h, or were heat shocked 20 min at 45uC and allowed to recover during 6 h. The relative quantity of Hsf2a and
Hsf2b transcripts was assessed by RT-PCR using primers flanking the alternative exon. Gapdh RT-PCR served as control for efficient retrotranscritpion
and amplification. (B) WT iMEFs were treated during 2 h, 4 h, 6 h or 10 h with MG132 at 1 mM or with DMSO before being harvested. In addition, WT
iMEFs exposed to MG132 during 10 h were allowed to recover during 1 h, 6 h or 24 h before collection. Relative quantity of Hsf2a and Hsf2b was
assessed by RT-PCR, as described above. Quantity one software (Bio Rad) was used to assess band intensity. Results were expressed in mean of
percentage of each isoform +/2 SD from four independent experiments. (C) WT iMEFs treated as described in (B) were harvested for protein analysis.
Protein extracts were loaded on 12% polyacrylamide gel and submitted to a long migration to separate efficiently HSF2 isoforms. HSF2 was revealed
by immunoblotting. Ponceau staining was used to verify the equal loading.
doi:10.1371/journal.pone.0056085.g004
Figure 5. Hsf2 deletion in blastocyst is characterized by a higher Hsp70 induction. (A) Relative quantity of total Hsf2 and Hsf2a transcripts
was assessed in blastocyst and testis using RT-real time PCR. Results are expressed as relative expression of Hsf2a compared to total Hsf2 and
correspond to the mean of two independent experiments. (B) Hsp70 induction after 4 h of MG132 treatment was assessed by RT-real time PCR in WT
and Hsf22/2 blastocysts. Results are expressed as fold induction of Hsp70 expression after MG132 treatment, normalized to DMSO for each sample,
and correspond to the mean of two independent experiments.
doi:10.1371/journal.pone.0056085.g005
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trimer, whereas HSF2b completely inhibits their activity. In
addition, HSF trimerization is assumed to occur when bound to
DNA, but not in solution. The 3 monomers are supposed to
trimerize with microscopic dissociation constants, K1 or K’1,
depending on whether they form homo- or hetero-trimer,
respectively. For symmetry reasons, one may expect that
homotrimers are favored (K1, K’1), but considering the close
structural relationship between the trimerization domains of the
different HSFs, K1 and K’1 could in fact be very similar. All types of
HSF trimers are supposed to bind to the DNA with the same
intrinsic dissociation constant K2. Global composite constants K or
K’ are defined such that K = K1
2 K2 and K’= K’1
2 K2 (M
3). There
are ten different possible types of trimers, distributing over 27
trimer microstates listed below, so that 11 possible states of HSE
can exist, either empty or bound by a HSF trimer. Finally, once
bound to DNA, HSF trimers devoid of HSF2b promote
transcription from an HSE-driven promoter with transcription
rates (time21), depending on the number of HSF1 protomers in
the trimer (k1, k2 and k3 for 1, 2 or 3 molecules of HSF1
respectively). Let us define the following variables: x = [HSF1*], the
concentration of transcriptionally active HSF1; a= [HSF2a] and
b= [HSF2b]T. The probability of the different binding states of
HSE can be defined as the ratio of their mass action values over
the sum of all of them, written S.
. P(HSE0)~1=S
. P(HSE-(HSF1)3)~(x3=K)=S
. P(HSE-(HSF2a)3)~(a
3=K)=S
. P(HSE-(HSF2b)3)~(b
3=K)=S
. P(HSE-(HSF1)2-HSF2a)~(3x
2a=K0)=S
. P(HSE-HSF1-(HSF2a)2)~(3xa
2=K0)=S
. P(HSE-(HSF1)2-HSF2b)~(3x
2b=K0)=S
. P(HSE-HSF1-(HSF2b)2)~(3xb
2=K0)=S
. P(HSE-(HSF2a)2-HSF2b)~(3a
2b)=K)=S
. P(HSE-HSF2a-(HSF2b)2)~(3ab
2=K)=S
. P(HSE-HSF1-HSF2a-HSF2b)~(6xab=K0)=S
To go further, a ratio of trimerization affinity is written R =K/
K’. In the experiment, the total amount of HSF2 is constant but
the ratio of the a and b isoforms is defined by a variable z= b/a.
The fixed total concentration of HSF2 is y = [HSF2] T =a+b, so
that a= y/(1+ z) and b= y z/(1+ z). The transcriptional activity (k)
of the HSE driven promoter can be defined as k=S ki Pi, where Pi
is the probability of presence of the HSF trimer responsible for the
maximal transcription initiation rate ki [18]. Using the rules and
values defined above, the global activity can be written after some
algebra
k~
k3x
3z3R k2
x2y
1zz
zk1
xy2
(1zz)2
 
Kzx3zy3z3Rxy(xzy)
ð1Þ
Finally in the experiment described above, the total concentra-
tion of transfected HSF is kept constant (x+y =H). Hence, a
variable can be eliminated from Eq. 1, yielding
k~
k3x
3z3R k2x
2 H{x
1zz
 
zk1x
H{x
1zz
 2" #
KzH3z3Hx(H{x)(R{1)
ð2Þ
Eq. 2 satisfactorily matches the experimental profile of the
global transcriptional activity obtained when increasing the
[HSF2b]/[HSF2a] ratio (Figure 3B). Modifying the relative
strength of homo- versus hetero-trimer formation has only
marginal influences (Figures 3C, D). Comparison between
Figure 3C and Figure 3B suggests that HSF heterotrimers should
be stable enough to explain the results, in agreement with the high
degree of conservation between the heptad repeat (HR) and the
DNA binding domain (DBD) of all HSFs involved in trimerization,
regardless of their capacity to initiate transcription.
Level of Proteasome Activity Regulates the Quantity of
Hsf2 Isoforms
The model described above suggests that the relative concen-
tration of HSF2 isoforms is involved in modulating the HSF1-
dependent transcriptional response. So, to assess the relative
quantity of each Hsf2 splicing isoforms in cells, RT-PCRs were
performed using MG132 treated, or heat shocked WT iMEFs total
RNA extracts (Figure 4A). In control and heat shocked cells, Hsf2b
was the dominant isoform, whereas in MG132-treated cells, Hsf2a
was found to be the major splicing isoform. From these
observations, it can be proposed that the way Hsf2 mRNA
splicing is regulated depends on the type of stress experienced by
the cells. This further implies a Hsf2a to b switch under MG132
treatment. The time course of such switch was analyzed during
MG132 exposure (10 h) and after a recovery period (from 1 to
24 h) (Figure 4B). Densitometric analysis showed that Hsf2b
represented about 55% of the total Hsf2 transcripts in control cells.
After 6 h of treatment, the relative quantity of Hsf2b decreased,
whereas the relative quantity of Hsf2a increased to become the
dominant isoform (around 55% of the total Hsf2 mRNA). This
switch between isoforms is a reversible phenomenon as observed
after 24 h of recovery, where the relative quantity of Hsf2a and
Hsf2b returned to their initial levels.
The switch in the mRNA isoforms was modest but highly
reproducible. Unfortunately, it was more challenging to confirm
the isoform switch at the protein level. The WT iMEFs were
treated with MG132 at 1 mM for 1 h, 6 h or 10 h and badges of
cells were harvested after 1 h, 6 h, 10 h or 24 h of recovery, to
detect HSF2 by immunoblot (Figure 4C). In control cells, HSF2a
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and HSF2b were barely detectable, because HSF2 is a labile
protein, constitutively expressed and degraded. During MG132
treatment, HSF2 was highly stabilized which adds an additional
level of regulation, in addition to the translation. Differences
between isoforms remained difficult to detect because of the lack of
sensitivity of the immunoblot method and the absence of isoform
specific antibodies.
Low Hsf2a/Hsf2b Ratio in Blastocyst is Associated with a
Weak Response to Proteasome Inhibition
HSF2 exhibits a developmentally regulated DNA binding
activity at the blastocyst stage (E 3.5 d) [19], which remains
unexplored so far. This prompted us to examine the relative
abundance of HSF2 isoforms, and the blastocyst response to
proteasome inhibition. Due to the limited amount of starting
material, we designed primers enabling real time RT-PCR to
amplify either the total Hsf2 cDNA, or specifically the a isoform.
For comparison, the same strategy was applied to testis total
extract (Figure 5A). In blastocysts, Hsf2a represented around 4%
of total Hsf2 transcripts (implying that the b isoform would count
for 96%), while in testis, the proportion of Hsf2a rose up to 46% of
Hsf2 total (Figure 5A). When WT blastocysts were treated with
MG132 for 4 h, Hsp70 expression assessed by real time RT-PCR
(Figure 5B) was only slightly induced (around 1.2 fold), compared
to non-treated ones. On the contrary, in Hsf22/2 blastocysts,
Hsp70 was 2.2 fold induced in MG132 treated versus non-treated
embryos. In accordance with our previous results, and speculating
that in WT blastocysts where HSF2b was the dominant isoform,
the response to proteasome inhibition was blunted. Conversely, in
Hsf22/2 blastocyst where there was no HSF2b protein, the Hsp70
response could be elicited.
Discussion
Both HSF1 and HSF2 exist as two main splicing isoforms, but
very few studies have focused on their respective transcriptional
activity. It is uneasy to address this question in cells expressing
endogenous HSF1 and 2, because of the coexistence of various
HSF complexes, either homo- or hetero-trimers, using potentially
both existing isoforms. Therefore, we took advantage of iMEFs
genetically depleted for both factors, which provide an invaluable
tool to dissect the precise role of each splicing isoforms of HSF1
and HSF2.
We found that HSF1a and HSF1b possessed distinct transcrip-
tional activities, HSF1a being a more potent activator under
proteasome inhibition. When HSF1 isoforms were discovered, the
authors hypothesized that HSF1a should be activated at higher
temperatures than HSF1b, because exon 11 encodes a putative
leucine zipper increasing the length of the HR-C domain, known
to stabilize HSF1 in the monomeric non-DNA binding form [9].
In our study, we showed that HSF1a had the same kinetic of
transcription activation than HSF1b, suggesting that these two
isoforms do not differ by their sensitivity to stress intensity but by
their transcriptional efficiency. Moreover, this difference in
transcriptional competency depends on the type of stress
experienced by the cells, since we found that the two isoforms
have the same transcriptional activities after heat shock treatment.
Regarding HSF2, previous works in yeast [20] and in K562
erythroleukemia cells [21–22] reported a modest, but detectable
transcriptional activity for HSF2. It was even suggested that the
short HSF2b isoform is a less potent activator than the long
HSF2a isoform [10]. Our study revealed that both HSF2 isoforms
are transcriptionally inefficient in our cellular model. Taken
together, these results suggest that HSF2 transcriptional activity
depends upon the cellular context and the presence of indispens-
able co-factors, or particular stimuli. The absence of HSF2
transcriptional activity also indicates that its main role is not to
directly recruit the transcriptional apparatus, but rather to play a
pioneer role in chromatin preparation. This hypothesis is in
agreement with the fact that HSF2 can prevent compaction of
HSF target genes during mitosis [23]. Our study confirmed the
role of HSF2 isoforms in the modulation of HSF1 activity
[11,17,24]. While HSF2a does not affect significantly HSF1
transcriptional activity, HSF2b clearly reduces HSF1 activity.
Moreover, this repression is specific to the association of HSF1b
with HSF2b, under MG132 treatment. Indeed, it was shown that
HSF2 is not activated after heat shock treatment, but rather after
inhibition of the ubiquitin-proteasome pathway [4]. Therefore,
HSF1-HSF2 heterotrimers can be assembled only after protea-
some inhibition, and not after heat shock [5], which might explain
why HSF2b inhibitory effect cannot be found after heat shock.
According to our results, the presence or absence of a short
isoform in the heterotrimer appears to be critical for this
modulation of HSF activity. We propose that the leucine zipper
conserved in the long isoform could create a novel interaction
domain. Thus, this domain could stabilize the activation domain
in an optimal conformation, while in the short isoforms, the
activation domains could be in a more relaxed conformation,
resulting in a less efficient co-factors binding, especially in the
context of an HSF1b-HSF2b heterotrimer.
The absence of specific antibody for each isoform, and the
technical limitations to accurately determine the ratio of isoforms
in a trimer, remain a real concern to further decipher HSF2
mechanism in HSF1 inhibition. In an attempt to alternatively
address this question, we have developed a mathematical
modelling approach. Our model is different from those previously
published on the dynamic of the eukaryotic heat shock response
[25–27]. In contrast with previous heat shock response models, we
did not focus on the various steps involved in the kinetics of Hsp
gene activation and its feedback regulation. We rather concen-
trated on the active HSF trimer that binds to the promoter. We
analyzed the impact of the presence of HSF2a and/or HSF2b
isoforms on the steady state of HSF1 activity. We postulated that
the presence of several HSF isoforms induces the coexistence of
different types of heterotrimers. These complexes do not equally
transactivate, and they are expected to compete to bind to target
promoters. The model we propose satisfies the experimental data
obtained by transfection. Based on this model, the strength of the
response depends on the proportion of each isoform in the cell.
Accordingly, the combination of HSF isoforms synthesized in each
cell determines the level of response. This implies that all the cells
do not have the same capabilities to respond to proteotoxic stress,
and that expression of these HSF isoforms is crucial for the
modulation of chaperone expression.
Expression of HSF2 isoforms is tissue-specific. For example
HSF2a is the main isoform in testis, while HSF2b is dominant in
brain [10]. In addition to this tissue-specific regulation of HSF
isoforms, we have shown that the differential splicing of Hsf1 and
Hsf2 messenger is also dependent on the type of stress. The switch
between the two isoforms is specific to proteasome inhibition, as
clearly shown by our RT-PCR experiments.
Taken together our data demonstrate how HSF1 and HSF2
splicing isoforms contribute a new level of complexity to HSF
regulation. Our results raise additional questions: how efficient is
the proteotoxic response in tissues where HSF1b and HSF2b are
dominant? Which evolutionary mechanisms established such
complex regulation of the relative quantity of HSF isoforms? It
might be critical for stressed cells to possess various ways to
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modulate HSF1 activity, to achieve better adaptation, and thus
survival. Heat shock is an acute stress with massive protein
alteration, which requires a rapid and high HSP expression. In
that case, HSF1 is found in homotrimeric complex, while HSF2
become insoluble and is found in the perinuclear fraction [28]. On
the other hand, proteasome inhibition induces a proteotoxic stress,
which can be considered as a chronic stress with the requirement
for longer-term adaptation. This should trigger a more limited
response, since it could be deleterious for cells or tissues to express
excessive amount of HSPs. Proteasome inhibition activates both
HSF1 and HSF2 [29], leading to the formation of a diverse
population of HSF heterotrimers, with variable transcriptional
efficiency [5]. This mechanism could be the best option to control
proteotoxic response in cells exposed to in case of chronic stress.
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